INSMED Inc
INSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001104506
In the last 90 days, INSMED Inc insiders filed 0 open-market purchases and 7 sales; 667 institutions reported holding it in 13F filings for Q2 2026, worth $23.8B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q1 2022
Institutional positions in INSMED Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- +13 vs. Q4 2021
- Shares held
- 126.5M
- +3.23M (+2.6%) vs. Q4 2021
- Total value
- $2.97B
- −$386.1M (−11.5%) vs. Q4 2021
- New holders
- 32
- 89 more added
- Sold out
- 19
- 70 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 667 | $23.8B |
| Q1 2026 | 675 | $35.7B |
| Q4 2025 | 678 | $37.8B |
| Q3 2025 | 566 | $30.3B |
| Q2 2025 | 516 | $21.2B |
| Q1 2025 | 442 | $15.3B |
| Q4 2024 | 439 | $13.3B |
| Q3 2024 | 414 | $13.7B |
| Q2 2024 | 378 | $11.7B |
| Q1 2024 | 288 | $4.07B |
| Q4 2023 | 271 | $4.64B |
| Q3 2023 | 252 | $3.72B |
| Q2 2023 | 223 | $3.09B |
| Q1 2023 | 230 | $2.48B |
| Q4 2022 | 225 | $2.87B |
| Q3 2022 | 238 | $2.74B |
| Q2 2022 | 214 | $2.55B |
| Q1 2022 | 224 | $2.97B |
| Q4 2021 | 214 | $3.36B |
| Q3 2021 | 193 | $3.40B |
| Q2 2021 | 203 | $3.46B |
| Q1 2021 | 199 | $3.63B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding INSMED Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Loomis Sayles & Co L P | 1,278,093 | $30.0M | 0.04% | −24,417−1.9% | Reduced |
| Suvretta Capital Management, LLC | 1,318,432 | $31.0M | 0.95% | +236,900+21.9% | Added |
| Avidity Partners Management LP | 1,354,539 | $31.8M | 0.71% | −95,461−6.6% | Reduced |
| Candriam Luxembourg S.C.A. | 1,458,474 | $34.3M | 0.23% | +492,719+51.0% | Added |
| Fairmount Funds Management LLC | 1,948,784 | $45.8M | 10.83% | +635,177+48.4% | Added |
| Geode Capital Management, LLC | 2,118,354 | $49.8M | 0.01% | +60,362+2.9% | Added |
| Baker Bros. Advisors LP | 2,156,001 | $50.7M | 0.29% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,364,660 | $55.6M | 0.25% | −34,592−1.4% | Reduced |
| Holocene Advisors, LP | 2,743,579 | $64.5M | 0.34% | +606,993+28.4% | Added |
| Alliancebernstein L.P. | 2,949,049 | $69.3M | 0.03% | +130,036+4.6% | Added |
| Franklin Resources Inc | 3,330,684 | $78.3M | 0.03% | +2,517+0.1% | Added |
| FMR LLC | 3,364,938 | $79.1M | 0.01% | −180,293−5.1% | Reduced |
| Macquarie Group Ltd | 3,375,105 | $79.3M | 0.07% | +195,222+6.1% | Added |
| Ameriprise Financial Inc | 3,484,229 | $81.9M | 0.02% | −674,193−16.2% | Reduced |
| Bellevue Group AG | 3,551,776 | $83.5M | 0.97% | +30,915+0.9% | Added |
| Pictet Asset Management SA | 3,555,849 | $83.6M | 0.09% | +657,094+22.7% | Added |
| William Blair Investment Management, LLC | 3,595,626 | $84.5M | 0.25% | −1,318,514−26.8% | Reduced |
| State Street Corp | 5,121,644 | $120.4M | 0.01% | +767,876+17.6% | Added |
| Palo Alto Investors LP | 5,881,299 | $138.2M | 10.69% | −144,407−2.4% | Reduced |
| Janus Henderson Group PLC | 7,678,266 | $180.4M | 0.09% | −203,292−2.6% | Reduced |
| BlackRock Inc. | 9,362,183 | $220.0M | 0.01% | +44,053+0.5% | Added |
| Vanguard Group Inc | 11,098,706 | $260.8M | 0.01% | −21,724−0.2% | Reduced |
| Price T Rowe Associates Inc | 15,858,261 | $372.7M | 0.04% | +537,057+3.5% | Added |
| International Biotechnology Trust PLC | 40,100 | – | – | −81,000−66.9% | Reduced |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −394,358−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −100,185−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −19,713−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −16,930−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −14,440−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −13,137−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −8,955−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −8,583−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −7,651−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −993−100.0% | Sold out |
| Paragon Capital Management Ltd | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |
| First Midwest Bank Trust Division | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |